Figure 5.
![Schematic overview of [13C6]glucose stable isotope tracings. (A) Tracing using [13C6]glucose including glycolytic and HMS pathways. (B) Tracing using [13C6]glucose in control and patient neutrophils before (time 0) and 5 minutes after incubation with 1 µM fMLF. Isotopologue intensities plotted correspond to labeling indicated in panel A (eg, 13C6 for glucose).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/4/23/10.1182_bloodadvances.2020002225/3/advancesadv2020002225f5.png?Expires=1723412039&Signature=3GljFwok-BYslmZP~~Awd053kF5yf4A6RbryBxNjv-oDeQ5UV6TywalQThc-oVKhJ5xd0wloxFSi5Pow4WfiFI6dGuTYatGrOe6SrJef-vUVIOaWCCXBTIm2zDOq95lnr7ONZQazwS1UwgZXWKUIHMpjVZB0UacmlJfip7kXI87tRwkW08q8Saifbh6INuYYP7QpoGE~5CNq~NWbXLIZbvdvi6vOdASGoJhKKGdkx0oE6SxGN2g~o0BowvcFe3VY2NufupusZT0l-~HWeRslNGX7vbOlQ97y13twRmvhNshb1Oq8q0RA2NusMPLF5mi3JoCMk5tl45CfH9mhKairRg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Schematic overview of [13C6]glucose stable isotope tracings. (A) Tracing using [13C6]glucose including glycolytic and HMS pathways. (B) Tracing using [13C6]glucose in control and patient neutrophils before (time 0) and 5 minutes after incubation with 1 µM fMLF. Isotopologue intensities plotted correspond to labeling indicated in panel A (eg, 13C6 for glucose).